Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Kardiologia Polska (Polish Heart Journal)
MENU
Shortcuts Online first Submit an article Reviewers 2021 Zeszyty Edukacyjne Author Guidelines Licence terms

open access

Vol 80, No 9 (2022)
Original article
Published online: 2022-06-10
View PDF Download PDF file View HTML Supp./Additional Files [1]
Get Citation

Neopterin as a predictive biomarker of postoperative atrial fibrillation following coronary artery bypass grafting

Anna Smukowska-Gorynia1, Bartłomiej Perek2, Marek Jemielity2, Anna Olasińska-Wiśniewska1, Justyna Marcinkowska3, Sebastian Stefaniak2, Artur Cieślewicz4, Sylwia Iwańczyk1, Maciej Lesiak1, Tatiana Mularek-Kubzdela1
DOI: 10.33963/KP.a2022.0143
·
Pubmed: 35698968
·
Kardiol Pol 2022;80(9):902-910.
Affiliations
  1. 1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland
  2. Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznań, Poland
  3. Department of Statistical Analyses and Computed Sciences, Poznan University of Medical Sciences, Poznań, Poland
  4. Department of Clinical Pharmacology, Poznan University of Medical Sciences, Poznań, Poland

open access

Vol 80, No 9 (2022)
Original article
Published online: 2022-06-10

Abstract

Background: The pathophysiology of postoperative atrial fibrillation (POAF) is multifactorial. Inflammation and increased oxidative stress play a significant role in POAF development. Neopterin, a biomarker of cellular immune response that enhances oxidative stress and increases the cytotoxic potential of activated macrophages and dendritic cells, was recently found as an independent predictive biomarker of non-operative atrial fibrillation. However, as far as we know, neopterin has never been investigated in POAF.
Aims: The study aimed to assess neopterin concentration as a prognostic biomarker of POAF following coronary artery bypass grafting (CABG).
Methods: One hundred one patients (80.2% males, 85% off-pump, 15% on-pump) were included. Blood samples were taken from patients for analysis of serum neopterin and high-sensitive C-reactive protein (hs-CRP) at three time points: (1) before operation (NP0); (2) on the first day after operation (NP1); and (3) between the fifth and eighth day after the procedure (NP5–8). All factors (preoperative, echocardiographic, and surgical), significant in univariate analysis, were included in a multivariable logistic regression analysis.
Results: POAF occurred in 30 patients (30%). In the analyzed multivariable logistic regression models, the independent predictors of POAF occurrence were: higher NP0 concentration (odds ratio [OR], 1.16; 95% confidence interval [CI], 1.02–1.38 for continuous and OR, 3.75; 95%  CI, 1.39–10.1 for NP0 cut-off >8.7 nmol/l), higher body mass index (OR, 1.15; 95% CI 1.02–1.29), history of pulmonary disease (OR, 6.72; 95% CI 1.57–28), increased diastolic thickness of the interventricular septum (OR, 1.45; 95% CI, 1.14–1.83), and duration of operation (OR, 1.01; 95% CI, 1.03–1.36).
Conclusions: We found that elevated neopterin concentration before CABG may be a predictive biomarker of POAF.

Abstract

Background: The pathophysiology of postoperative atrial fibrillation (POAF) is multifactorial. Inflammation and increased oxidative stress play a significant role in POAF development. Neopterin, a biomarker of cellular immune response that enhances oxidative stress and increases the cytotoxic potential of activated macrophages and dendritic cells, was recently found as an independent predictive biomarker of non-operative atrial fibrillation. However, as far as we know, neopterin has never been investigated in POAF.
Aims: The study aimed to assess neopterin concentration as a prognostic biomarker of POAF following coronary artery bypass grafting (CABG).
Methods: One hundred one patients (80.2% males, 85% off-pump, 15% on-pump) were included. Blood samples were taken from patients for analysis of serum neopterin and high-sensitive C-reactive protein (hs-CRP) at three time points: (1) before operation (NP0); (2) on the first day after operation (NP1); and (3) between the fifth and eighth day after the procedure (NP5–8). All factors (preoperative, echocardiographic, and surgical), significant in univariate analysis, were included in a multivariable logistic regression analysis.
Results: POAF occurred in 30 patients (30%). In the analyzed multivariable logistic regression models, the independent predictors of POAF occurrence were: higher NP0 concentration (odds ratio [OR], 1.16; 95% confidence interval [CI], 1.02–1.38 for continuous and OR, 3.75; 95%  CI, 1.39–10.1 for NP0 cut-off >8.7 nmol/l), higher body mass index (OR, 1.15; 95% CI 1.02–1.29), history of pulmonary disease (OR, 6.72; 95% CI 1.57–28), increased diastolic thickness of the interventricular septum (OR, 1.45; 95% CI, 1.14–1.83), and duration of operation (OR, 1.01; 95% CI, 1.03–1.36).
Conclusions: We found that elevated neopterin concentration before CABG may be a predictive biomarker of POAF.

Full Text:

View PDF Download PDF file View HTML Supp./Additional Files [1]
Get Citation

Keywords

coronary artery bypass grafting, inflammatory biomarker, neopterin, postoperative atrial fibrillation

Supp./Additional Files (1)
Supplementary material
Download
161KB
About this article
Title

Neopterin as a predictive biomarker of postoperative atrial fibrillation following coronary artery bypass grafting

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 80, No 9 (2022)

Article type

Original article

Pages

902-910

Published online

2022-06-10

Page views

1224

Article views/downloads

185

DOI

10.33963/KP.a2022.0143

Pubmed

35698968

Bibliographic record

Kardiol Pol 2022;80(9):902-910.

Keywords

coronary artery bypass grafting
inflammatory biomarker
neopterin
postoperative atrial fibrillation

Authors

Anna Smukowska-Gorynia
Bartłomiej Perek
Marek Jemielity
Anna Olasińska-Wiśniewska
Justyna Marcinkowska
Sebastian Stefaniak
Artur Cieślewicz
Sylwia Iwańczyk
Maciej Lesiak
Tatiana Mularek-Kubzdela

References (37)
  1. Lo B, Fijnheer R, Nierich AP, et al. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg. 2005; 79(5): 1530–1535.
    CrossRefPubMed
  2. Ahlsson A, Fengsrud E, Bodin L, et al. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg. 2010; 37(6): 1353–1359.
    CrossRefPubMed
  3. LaPar DJ, Speir AM, Crosby IK, et al. Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann Thorac Surg. 2014; 98(2): 527–33; discussion 533.
    CrossRefPubMed
  4. Fan G, Wei J. Identification of potential novel biomarkers and therapeutic targets involved in human atrial fibrillation based on bioinformatics analysis. Kardiol Pol. 2020; 78(7-8): 694–702.
    CrossRefPubMed
  5. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997; 96(10): 3542–3548.
    CrossRefPubMed
  6. Hak Ł, Myśliwska J, Wieckiewicz J, et al. Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG). J Interferon Cytokine Res. 2009; 29(6): 327–332.
    CrossRefPubMed
  7. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 2003; 108 Suppl 1: II195–II199.
    CrossRefPubMed
  8. Enc Y, Ketenci B, Ozsoy D, et al. Atrial fibrillation after surgical revascularization: is there any difference between on-pump and off-pump? Eur J Cardiothorac Surg. 2004; 26(6): 1129–1133.
    CrossRefPubMed
  9. Czerny M, Zimpfer D, Kilo J, et al. Complete revascularization in coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg. 2001; 71(1): 165–169.
    CrossRefPubMed
  10. Boyd WD, Desai ND, Del Rizzo DF, et al. Off-pump surgery decreases postoperative complications and resource utilization in the elderly. Ann Thorac Surg. 1999; 68(4): 1490–1493.
    CrossRefPubMed
  11. Panesar SS, Athanasiou T, Nair S, et al. Early outcomes in the elderly: a meta-analysis of 4921 patients undergoing coronary artery bypass grafting--comparison between off-pump and on-pump techniques. Heart. 2006; 92(12): 1808–1816.
    CrossRefPubMed
  12. Mentese U, Dogan OV, Turan I, et al. Oxidant-antioxidant balance during on-pump coronary artery bypass grafting. ScientificWorldJournal. 2014; 2014: 263058.
    CrossRefPubMed
  13. Kim YM, Kattach H, Ratnatunga C, et al. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008; 51(1): 68–74.
    CrossRefPubMed
  14. Ramlawi B, Otu H, Mieno S, et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg. 2007; 84(4): 1166–72; discussion 1172.
    CrossRefPubMed
  15. Weiss G, Fuchs D, Hausen A, et al. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett. 1993; 321(1): 89–92.
    CrossRefPubMed
  16. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res. 2003; 52(8): 313–321.
    CrossRefPubMed
  17. Kaski JC, Consuegra-Sanchez L, Fernandez-Berges DJ, et al. SIESTA Investigators. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis. 2008; 201(1): 176–183.
    CrossRefPubMed
  18. Wietlicka-Kokoszanek I, Jablecka A, Smolarek I, et al. Neopterin as a prognostic marker in patients with chronic heart failure. Med Sci Monit. 2010; 16(5): CR232–CR237.
    PubMed
  19. Yamamoto E, Hirata Y, Tokitsu T, et al. The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction. ESC Heart Fail. 2016; 3(1): 53–59.
    CrossRefPubMed
  20. Smukowska-Gorynia A, Marcinkowska J, Chmara E, et al. Neopterin as a Biomarker in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Respiration. 2018; 96(3): 222–230.
    CrossRefPubMed
  21. Adamik B, Kübler-Kielb J, Golebiowska B, et al. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med. 2000; 26(9): 1259–1267.
    CrossRefPubMed
  22. Berg KS, Stenseth R, Pleym H, et al. Neopterin predicts cardiac dysfunction following cardiac surgery. Interact Cardiovasc Thorac Surg. 2015; 21(5): 598–603.
    CrossRefPubMed
  23. Osse RJ, Fekkes D, Tulen JHM, et al. High preoperative plasma neopterin predicts delirium after cardiac surgery in older adults. J Am Geriatr Soc. 2012; 60(4): 661–668.
    CrossRefPubMed
  24. Ayaz L, Unlu A, Sucu N, et al. Role of neopterin, C-reactive protein and myeloperoxidase in patients undergoing cardiopulmonary bypass. Med Princ Pract. 2010; 19(6): 479–484.
    CrossRefPubMed
  25. Zuo H, Nygård O, Ueland PM, et al. Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies. J Intern Med. 2018; 283(6): 578–587.
    CrossRefPubMed
  26. Sazonova SI, Ilushenkova JN, Batalov RE, et al. Plasma markers of myocardial inflammation at isolated atrial fibrillation. J Arrhythm. 2018; 34(5): 493–500.
    CrossRefPubMed
  27. Barani J, Mattiasson I, Lindblad B, et al. Cardiac function, inflammatory mediators and mortality in critical limb ischemia. Angiology. 2006; 57(4): 437–444.
    CrossRefPubMed
  28. Lewicka E, Dudzinska-Gehrmann J, Dabrowska-Kugacka A, et al. Neopterin and interleukin-6 as predictors of recurrent atrial fibrillation. Anatol J Cardiol. 2016; 16(8): 563–571.
    CrossRefPubMed
  29. Cichoń M, Mizia-Szubryt M, Olszanecka-Glinianowicz M, et al. Biomarkers of left atrial overload in obese and nonobese patients with atrial fibrillation qualified for electrical cardioversion. Kardiol Pol. 2021; 79(3): 269–276.
    CrossRefPubMed
  30. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004; 291(14): 1720–1729.
    CrossRefPubMed
  31. Bramer S, van Straten AHM, Soliman Hamad MA, et al. Body mass index predicts new-onset atrial fibrillation after cardiac surgery. Eur J Cardiothorac Surg. 2011; 40(5): 1185–1190.
    CrossRefPubMed
  32. Fontes ML, Amar D, Kulak A, et al. Increased preoperative white blood cell count predicts postoperative atrial fibrillation after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2009; 23(4): 484–487.
    CrossRefPubMed
  33. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001; 104(24): 2886–2891.
    CrossRefPubMed
  34. Kaireviciute D, Blann AD, Balakrishnan B, et al. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb Haemost. 2010; 104(1): 122–127.
    CrossRefPubMed
  35. Ahlsson AJ, Bodin L, Lundblad OH, et al. Postoperative atrial fibrillation is not correlated to C-reactive protein. Ann Thorac Surg. 2007; 83(4): 1332–1337.
    CrossRefPubMed
  36. Weymann A, Popov AF, Sabashnikov A, et al. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis. Kardiol Pol. 2018; 76(2): 440–451.
    CrossRefPubMed
  37. Manfrini O, Cenko E, Ricci B, et al. Post Cardiovascular Surgery Atrial Fibrillation. Biomarkers Determining Prognosis. Curr Med Chem. 2019; 26(5): 916–924.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl